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Pharmacologic stress with dipyridamole has provided useful diag-
nostic, as weD as prognostic, information in patients undergoing 
thallium-201 myocardial perfusion imaging. With its ultrashort 
half-life and a potent and consistent vasodilator effect, adenosine 
may be the coronary vasodilator of choice with myocardial 
perfusion imaging. 
Fifty-one healthy subjects and 93 patients with suspected 
coronary artery disease constituted the study group. In this 
multicenter study the comparative safety and diagnostic efficacy of 
single-photon emission computed tomography (SPECT) thallium 
imaging during adenosine-induced coronary hyperemia was com-
pared with exercise treadmill stress. There was a mean increase in 
heart rate of 37% and a mean decrease in diastolic blood pressure 
of 5% during the adenosine infusion of 140 /Lg/kg per min for 
6 min. Adenosine infusion was well tolerated in 95% of the 
subjects. Side effects requiring intervention occurred in seven 
Pharmacologic coronary vasodilation with dipyridamole has 
been proposed as an alternative to exercise stress with 
thallium-201 perfusion imaging (l-4). Pharmacologic stress 
is useful for the noninvasive diagnosis of coronary artery 
disease, especially in patients who cannot adequately exer-
cise (5,6). Dipyridamole thallium-201 scintigraphy has dem-
onstrated diagnostic utility in the detection of angiographi-
cally significant coronary disease with relatively high 
sensitivity and specificity (2,7 ,8). Dipyridamole imaging has 
also provided useful prognostic information by accurately 
identifying patients at risk for complications after myocar-
dial infarction (9-11) or before noncardiac surgery (12). 
Dipyridamole may not be the ideal coronary vasodilator. 
The major limitation to its use is the submaximal coronary 
vasodilation that may occur in up to 50% of patients who 
receive the recommended intravenous dipyridamole dose 
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subjects (5% ). None of the subjects experienced a life-threatening 
complication. 
The sensitivity, specificity and predictive accuracy for detec-
tion of coronary artery disease with use of quantitative analysis 
was 83%, 87% and 84% for adenosine SPECT and 82%, 80% 
and 81% for exercise SPECT studies, respectively. Most false 
negative results with adenosine, as well as exercise SPECT studies, 
occurred in patients with single-vessel disease. The first-order 
concordance (no defect vs. defect) and second-order concordance 
(no defect vs. irreversible vs. reversible defect) was 89% and 78% 
between the two studies, respectively. 
Thus, the results of adenosine SPECT imaging are highly 
concordant with exercise SPECT thallium imaging. Adenosine 
SPECT thallium imaging provides a safe and highly accurate 
imaging mode for the detection of coronary artery disease. 
(JAm Coli Cardiol1992;19:248-57) 
(140 /Lg/kg per min for 4 min) (13). The addition of isometric 
handgrip to dipyridamole does not significantly augment 
coronary blood flow (13). When side effects occur with 
dipyridamole, they are often persistent because of the drug's 
relatively long half-life, as evidenced by the frequent need 
for aminophylline reversal (14). 
Recent preliminary evidence suggests that adenosine may 
be a useful coronary vasodilator (15-17). An intravenous dose 
of 140 J.Lg/kg per min produces maximal or near maximal 
coronary vasodilation in 92% of patients (18). In addition, its 
short half-life ( < 10 s) (19) obviates the need for theophylline 
reversal of side effects. The present study was a crossover 
comparison of adenosine thallium-201 single-photon emission 
computed tomography (SPECT) and exercise treadmill stress 
thhllium-201 SPECT in both healthy subjects and patients with 
angiographically documented coronary artery disease. A fully 
blinded comparison between these two methods in the same 
group of patients has not been previously reported. 
Methods 
Study patients (Table 1). A total of 144 subjects were 
recruited from nine centers to participate in this study, 
0735-1097/92/$5.00 
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Table 1. Demographic Characteristics of the 
Study Group (n = 144) 
Healthy 
Volunteers Patients 
Number 51 93 
Age (yr) 31.8 ± 9.5 57.9 ± 10.3 
Male/female ratio 31/20 77/16 
Angina pectoris NA 80 (86) 
Prior MI (by ECG) NA 37 (40) 
Prior CABG surgery NA 13 (14) 
Hypertension NA 42 (45) 
Congestive heart failure NA 8 (9) 
Cardiac medication 
Beta-blocker NA 7 (8) 
Calcium channel blocker NA !I (12) 
Nitrate NA 30 (32) 
Coronary anatomy 
OVD NA 17 (18) 
I VD NA 37 (40) 
2VD NA 22 (24) 
3 VD NA 17 (18) 
Numbers in parentheses represent percent. CABG = coronary artery 
bypass graft; ECG = electrocardiogram; MI = myocardial infarction; NA = 
not applicable; VD = vessel disease (>50% diameter stenosis). 
which was approved by the Institutional Review Boards of 
the participating centers (see Appendix). All patients gave 
written informed consent. The study group included 51 
healthy volunteers and 93 patients who had angiographically 
defined coronary anatomy. Eligible subjects, except healthy 
volunteers, underwent both exercise and adenosine SPECT 
thallium imaging within 6 weeks after coronary arteriogra-
phy. Clinical characteristics of the subjects are summarized 
in Table 1. The healthy volunteers had a <5% pretest 
probability of having coronary artery disease as assessed by 
standard criteria (20). Both healthy subjects and patients 
were judged to be physically able to perform an upright 
treadmill exercise stress test. 
Exclusion criteria for our study included myocardial 
infarction in the previous week; unstable angina; hypoten-
sion (systolic blood pressure <90 mm Hg); hypertension 
(systolic or diastolic blood pressure >200 or> 110 mm Hg, 
respectively); New York Heart Association class IV conges-
tive heart failure; greater than first-degree atrioventricular 
(A V) block, unless protected by a permanent pacemaker; 
and asthma or obstructive lung disease. Dipyridamole and 
methylxanthine compounds were discontinued 24 h before 
the thallium-201 studies. There were no restrictions on other 
medication use. 
Exercise and adenosine thallium-201 protocol. Exercise 
testing was performed in the fasting state. Treadmill stress 
testing was performed with use of a standard Bruce or 
Naughton protocol to the end points of 85% of age-predicted 
maximal heart rate, moderate to severe angina, excessive 
fatigue, dyspnea, hypertension, silent ischemia (>2 mm ST 
segment depression) or significant arrhythmias. Ischemic 
changes were defined as > 1 mm horizontal or downsloping 
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Figure 1. Adenosine SPECT (AI) imaging protocol with use of the 
6-min adenosine infusion (140 ~-tg/kg per min). BP= blood pressure; 
EKG = electrocardiogram; HR = heart rate; IV = intravenous. 
ST segment depression 80 ms after the J point that persisted 
for at least 1 min after termination of exercise. Thallium-201, 
3.5 mCi, was given intravenously approximately 1 min 
before the symptom-limited maximal exercise end point was 
reached. Standard electrocardiographic (ECG) leads 11, a VF 
and V 5 were monitored continuously. 
Adenosine protocol (Fig. 1). Adenosine (Adenoscan) was 
infused through a peripheral vein at 140 ,ug/kg per min for 
6 min. Patients were instructed to fast overnight and to avoid 
caffeinated beverages for at least 24 h before the study. At 
3 min into the infusion, 3.5 mCi of thallium-201 was injected 
as a bolus and flushed with normal saline solution. Three 
ECG leads (11, a VF and V 5) were continuously monitored 
throughout the test with vital signs and a 12-lead ECG was 
obtained before, at every minute during and for 3 min after 
the end of adenosine infusion. 
Coronary arteriography and interpretation. Selective 
coronary arteriography was performed by the Judkins tech-
nique. Coronary arteriograms were interpreted by two ex-
perienced independent observers at each investigational site 
without knowledge of scintigraphic results. The severity of 
coronary stenosis was assessed visually and expressed as 
percent lumen diameter stenosis. Individual maps were 
made showing the relative size and distribution of each 
patient's major coronary arteries and the location and sever-
ity of all coronary stenoses. Seventy-six of the 93 subjects 
who underwent angiography were found to have coronary 
artery disease defined as >50% stenosis measured in one or 
more coronary arteries. Of these 76 subjects, 37 (40%) had 
single-, 22 (24%) had double- and 17 (18%) had triple-vessel 
disease. The left anterior descending coronary artery was 
involved in 44 patients, the left circumflex coronary artery in 
42 and the right coronary artery in 46. Of the 17 patients who 
had <50% coronary artery obstruction, 3 had a prior myo-
cardial infarction, 5 had symptoms suggestive of classic 
angina pectoris and 9 had no evidence of heart disease. 
Thallium-201 myocardial imaging and interpretation. 
Single-photon emission computed tomography (SPECT) im-
ages were acquired at all investigative sites with a large 
field-of-view rotating gamma camera (General Electric) 
equipped with a low-energy collimator and interfaced to a 
Starcam computer. Early and delayed (4 h after thallium-
201) images were obtained over a 180° arc (32 images/study; 
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40 s/image), spanning from 45° right anterior oblique to 4SO 
right posterior oblique. The pulse height analyzer of the 
camera was set with a 15% window centered on the 80 keY 
photo-peak. Imaging began within 5 min after completion of 
the adenosine infusion or after the end of exercise stress and 
was repeated 4 h later. Images were acquired at 6° intervals 
for 32 stops with 40 s/image on a 64 x 64 x 8 bite matrix and 
stored on floppy disks for subsequent analysis at the core 
facility. 
Each projection was corrected for nonuniformity with use 
of 30 million counts cobalt-57 extrinsic flood. A standard 
filtered back projection technique was applied with use of 
the Ramp/Hanning filter with cutoff frequency of 0.83 cy-
cles/cm to generate a transaxial slice. No scatter or attenu-
ation correction was used. From these transaxial slices, the 
long axis of the left ventricle was identified and oblique angle 
image slices were generated in the short-axis, horizontal 
long-axis and vertical long-axis orientations. To detect mo-
tion artifact , soft tissue attenuation artifact and extracardiac 
thallium uptake, planar images were reviewed in a cine loop 
mode. Also, a sinogram using cross-correlation function was 
inspected to look for any abrupt motion during the image 
acquisition. For ease in interpretation, initial and 4-h delayed 
slices were displayed on the color monitor with initial 
tomograms on the top and corresponding redistribution 
slices on the bottom of the screen with appropriate display 
window. Myocardial segments with diminished uptake and 
complete redistribution in the delayed images involving 
>25% of the segment were considered ischemic. Segments 
with partial redistribution (defined as any amount of defect 
improvement without complete normalization) were consid-
ered to have both ischemia and scar. Defects without redis-
tribution were defined as scar. 
Initial and 4-h delayed images were interpreted in the core 
facility by a single experienced observer (nuclear medicine 
physician) who did not know the results of cardiac catheter-
ization or clinical information. The SPECT studies in 66 
normal subjects (including healthy volunteers with <5% 
probability of disease and subjects with normal angiographic 
findings) and 68 subjects with abnormal angiographic find-
ings were considered optimal for qualitative analysis. The 
perfusion abnormalities were assigned to the six myocardial 
segments: anterior, septal, apical, inferior, anterolateral and 
posterolateral walls. 
The myocardial segmental distribution of the coronary 
arteries was defined as follows: septal and anterior segments 
corresponded to the left anterior descending, inferior and 
posterior segments to the right and lateral segments to the 
left circumflex coronary artery. The vascular distribution of 
apical defects was considered separately in each case de-
pending on defects in other vascular territories. An image 
was considered abnormal if there was a decrease by visual 
inspection in the thallium-201 uptake in any myocardial 
segment. Early stress tomograms were analyzed slice by 
slice and each of the three major coronary vascular distri-
butions were assigned a regional perfusion score as follows: 
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0 = normal perfusion, 1 = mild hypoperfusion, 2 = moderate 
hypoperfusion and 3 = severe hypoperfusion. Early stress 
and delayed redistribution tomograms were compared slice 
by slice and assigned a global defect score as follows: 0 = no 
defect, 1 = completely reversible defect, 2 = partially 
reversible defect and 3 = irreversible defect. 
The intraobserver variability for visual interpretation of 
the scans was analyzed with use of a random sample of 20 
adenosine SPECT and exercise SPECT studies. The intraob-
server error was 5%. 
Computer quantitation of tomographic imaging (polar 
map). Thallium-201 tomograms were quantified with use of 
computerized two-dimensional polar maps (bull's-eye) of 
radionuclide activity. The distribution of radioactivity was 
determined for each tomographic slice with use of the 
circumferential profile technique. The normalized short-axis 
circumferential profiles were then color coded and displayed 
as concentric rings from cardiac apex to base. Apical images 
were defined from the short and vertical long-axis slices and 
displayed on the central polar map. Each polar map was then 
specifically compared with lower limits of a normal file 
determined from pooled profiles of 40 normal male and 26 
normal female subjects. These data were transformed into a 
polar plot known as a bull's-eye map on the StarCam 
(General Electric) computer. 
New male and female normal limits were created with use 
of the pooled profiles from studies on 40 normal male and 26 
normal female subjects . Separate reference normal limit files 
were generated for exercise SPECT and adenosine SPECT 
studies in the StarCam Computer. The mean and standard 
deviation limits for the new normal files were created. All the 
studies on angiographic abnormal subjects were first normal-
ized and then analyzed by comparison with new normal limit 
profiles. Patient profiles were compared against the mean 
value minus 2.5 SDs from the mean normal response (1.5 SD 
for reversibility). The reversibility polar maps assist in 
differentiating whether a stress perfusion defect begins to 
normalize by 4 h (reverses) or whether it remains unchanged 
(fixed). The computer color-coded the pixels with count 
activity >2.5 SD below the mean normal count activity. For 
each stress defect the following variables were computed: 
stress defect extent, stress defect severity (sum of standard 
deviations below the mean in stress defect), degree of 
reversibility extent (number of pixels in the stress defect that 
have reversed), degree of reversibility severity (number of 
standard deviations above the mean for pixels within stress 
defect that have reversed) and percent reversed. 
We also performed a region of interest analysis on the 
anterior frame of the acquired tomographic data of adeno-
sine and exercise poststress and delayed studies. Two rect-
angular regions of 3 x 3 pixel size each were drawn over the 
hottest region of the myocardium and the left lung region. 
These regions were drawn on the anterior frame acquired 
over a 40-s duration. Lung/heart ratios were then obtained 
for individual patients with use of the counts in these drawn 
regions on the adenosine and exercise studies. 
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Table 2. Hemodynamic Effects of Adenosine in 144 Subjects 
Baseline Peak p Value 
Heart rate (beats/min) 67 ± 13 91 ± 18 0.001 
Systolic BP (mm Hg) 123 ± 16 115 ± 15 NS 
Diastolic BP (mm Hg) 78 ± 14 74 ± 12 NS 
Rate-pressure product 
(beats/min x mm Hg x I 03 8.2 ± 2.1 10.5 ± 2.7 0.02 
BP = blood pressure. 
Statistical analysis. The following calculations were used: 
Sensitivity (%) = 100 x (True positives)/(True positives + 
False negatives); Specificity (%) = 100 x (True negatives)/ 
(True negatives + False positives); Positive predictive value 
(%) = 100 x (True positives)/(True positives - False posi-
tives); Negative predictive value (%) = (True negatives)/ 
(True negatives + False negatives); and Predictive accuracy 
(%) = 100 x (True positives +True negativesffotal number 
of tests). The 95% confidence intervals were used when 
indicated. 
Agreement between paired exercise and adenosine tomo-
grams was determined by first and second order analysis 
using 2 x 2 (no defect vs. defect) and 3 x 3 (no defect vs. 
irreversible defects) tables, respectively. Agreement was 
evaluated with use of the McNemar statistic. Agreement was 
defined as a kappa score >0.4. 
Student t tests for paired data were used to analyze ECG, 
hemodynamic and side effect variables that were normally 
distributed. Variables with a nonnormal distribution were an-
alyzed by the Wilcoxon signed-rank test. A p value <0.05 was 
considered significant. Values are given as mean values ± SD. 
Results 
Hemodynamic effect (Tables 2 and 3). Adenosine induced 
statistically insignificant reductions in the mean systolic and 
Table 3. Comparison of Adenosine and Exercise Testing in the 
144 Subjects 
Adenosine Exercise p Value 
Peak heart rate (beats/rnin) 91 ± 18 149 ± 24 0.0001 
Heart rate* (beats/min) 24 ± 14 74 ± 28 0.0001 
Peak systolic BP (mm Hg) 128 ± 16 167 ± 30 0.0001 
Peak systolic BP (mm Hg)* 5 ± 12 46 ± 20 0.0001 
Peak rate-pressure product 11 ± 3 25 ± 6 0.0001 
(beats/min x mm Hg x W) 
llpeak rate-pressure product* 3 ± 2 16 ± 5 0.0001 
(beats/min x mm Hg x I 03) 
Chest pain during test 35 (24) 21 (15) 0.02 
ST1 during test 12 (8) 20 (14) 0.04 
Both chest pain and ST1 during 11 (8) 14 (10) NS 
test 
Exercise time (min) 8 ± 3 
Exercise work load (METs) 9 ± 3 
*Changes from baseline values to peak effect. Numbers in parentheses 
represent percent. BP = blood pressure. ST1 = ST segment depression 
>I mm. 
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diastolic blood pressures in both the patients and the healthy 
subjects measured at each minute of the infusion. The mean 
reduction in systolic and diastolic blood pressures in 144 
subjects was 6% and 5%, respectively. Adenosine increased 
the heart rate by 32% in patients, 46% in healthy volunteers 
and 36% in the entire group. The heart rate-systolic pressure 
(rate-pressure) product was increased by 28% for the entire 
group. 
Mean exercise duration for patients, healthy volunteers 
and the entire group was 8.3 ± 3.5, 12.0 ± 4.5 min and 9.6 ± 
3.9 min, respectively. All 51 healthy subjects achieved at 
least 85% of age-predicted maximal heart rate during exer-
cise, whereas 74 (80%) of the 93 patients achieved 85% of 
their age predicted maximum. Mean peak heart rate 
achieved by patients, healthy volunteers and the entire 
group was 137.6 ± 21.1, 169.8 ± 28.7 and 149.0 ± 
23.8 beats/min, respectively. Mean peak systolic blood pres-
sure achieved in patients, healthy volunteers and the entire 
group was 168.3 ± 32.5, 165.0 ± 26.0 and 167.1 ± 
30.2 mm Hg, respectively. The increase in the rate-pressure 
product achieved by patients, healthy volunteers and the 
entire group was 147%, 242% and 174%, respectively. 
Electrocardiographic changes. Adenosine increased the 
PR interval by 6%, had no effect on the QRS interval and 
decreased the QT interval by 5%. ST segment depression 
indicative of myocardial ischemia occurred during adenosine 
infusion in 12 patients, of whom 11 also experienced chest 
pain. Chest pain occurred in 35 patients during the adenosine 
infusion. During the adenosine infusion, the incidence of 
first-degree A V block (PR interval >0.24 s) was 2.1% (three 
cases). One subject (0. 7%) developed second-degree A V 
block lasting only 4 s. No subject required adjustment or 
termination of adenosine infusion for arrhythmias. 
Exercise induced a 13% decrease in the PR interval, no 
change in the QRS interval and a 30% decrease in the QT 
interval. Twenty patients developed > 1 mm ST segment 
depression during exercise stress testing, of whom four also 
had chest pain. 
Side effects (Table 4). The 6-min 0.14-mg/kg per min 
adenosine infusion caused no side effects in 26 subjects 
(18%). In the remaining I 18 subjects, one or more side 
effects were reported. The most common side effects with 
adenosine were flushing (41%), chest pain (24%), dyspnea 
(23%), throat or neck tightness (20%) and dizziness (20%). 
However, these were well tolerated in all except seven 
patients (5%). In one of these subjects the adenosine dose 
was reduced, in two the adenosine infusion was stopped 
prematurely and in four aminophylline was administered 
after completion of the adenosine infusion for reversal of 
side effects (chest pain, dyspnea, headache and light-
headedness). No subject experienced a life-threatening or 
serious adverse reaction, such as myocardial infarction, 
hypotension (systolic blood pressure <90 mm Hg) or com-
plete heart block. 
Qualitative image analysis. A total of 134 (93%) of the 144 
subjects had stress and redistribution scintigrams judged to 
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Table 4. Incidence of Cardiac and Noncardiac Side Effects From 
Adenosine Infusion in 144 Patients 
Side Effects No.(%) 
Cardiac 
Chest pain 35 (24) 
Dyspnea 33 (23) 
ST >I mm 12 (8) 
! 0 AV block 3 (2) 
2° AV block I (I) 
3° AV block 0 
Noncardiac 
Flushing 59 (41) 
Temporal mandibular 29 (20) 
joint discomfort 
Lightheadedness 29 (20) 
Nausea 15 (10) 
Headache 17 (12) 
Paresthesia 6 (4) 
Miscellaneous 10 (7) 
Total number of patients reporting side effects = 118 (82). ! 0 , 2°, 3° AV 
block = first-, second- and third degree atrioventricular block, respectively. 
be technically optimal for visual analysis. Ten patients with 
technically inadequate scans were included in the safety 
analysis. The sensitivity, specificity and predictive accuracy 
for detection for coronary artery disease was 81%, 80% and 
81%, respectively, for adenosine and 80%, 79% and 80%, 
respectively, for exercise SPECT studies as assessed by 
angiographic results. 
Concordance between adenosine and exercise (Fig. 2 and 
3). First-order analysis (no defect vs. defect) showed an 
89% (119/134) concordance between adenosine and exercise 
studies (k = 0.7756; p < 0.0001). Of the 15 subjects with 
discordant results, 9 were healthy volunteers and 6 were 
subjects who underwent angiography (4 with >50% coro-
nary stenosis and 2 with normal coronary arteries). Of the 
nine healthy volunteers with discordant results, seven had a 
defect (irreversible in five and reversible in two) after 
adenosine stress and two had a defect with exercise stress 
(reversible in one and irreversible in one). Among the six 
Figure 2. Comparative efficacy of adenosine SPECT (AI) and exer-
cise treadmill SPECT (ET) studies for detection of coronary artery 
disease. 
AI- Adenosine SPECT (quantitative) c=:J 
ET- Exercise SPECT (quantitative) ~ 
86.6% 





















Figure 3. Concordance between 134 adenosine SPECT and exercise 
treadmill SPECT studies for detection of individual coronary artery 
lesions. LAD = left anterior descending coronary artery; LCX = 
left circumflex coronary artery; RCA = right coronary artery. 
patients with discordant results, coronary artery disease was 
correctly predicted by adenosine stress in three and by 
exercise in the other three. No difference in the frequency of 
first-order discordance was observed when patients were 
stratified according to percent maximal coronary stenosis, 
number of coronary arteries with >50% stenosis or the 
coronary artery with the predominant lumen stenosis. 
Second-order concordance analysis revealed that 78% of 
adenosine and exercise studies agreed with regard to both 
the presence or absence, and the reversibility or irreversibil-
ity of perfusion defects (k = 0.6425; p < 0.0001). Second-
order discordance occurred in 5 healthy volunteers and 10 
patients. Among the 10 patients, an irreversible perfusion 
defect was seen in only 1 patient after adenosine stress and 
in 9 patients after exercise stress. Subgroup analysis of the 
subjects with second-order discordance did not reveal any 
trends based on coronary anatomy or severity of coronary 
stenosis. 
Quantitative analysis (Fig. 4). After the creation of the 
bull's-eye polar plots, the total extent (number ofpixels) and 
severity scores for each stress defect were assessed by 
comparison with the respective (male or female and adeno-
sine or exercise) normal file. The number of standard devi-
ations for degree of reversibility severity, and the extent (the 
number of pixels within a stress defect that have reversed) of 
reversibility were also computed. The quantitative data on 
66 patients with angiographically proved coronary artery 
disease (two patient studies could not be reliably quanti-
tated) and 40 randomly selected normal subjects (including 
25 healthy volunteers with <5% probability of disease and 15 
subjects with normal angiographic findings) were further 
analyzed with use of the bull's-eye analysis program for 
comparison of paired adenosine SPECT and exercise tread-
mill SPECT studies. Focal defects involving > 3% of total 
left ventricular pixels were considered abnormal. 
Quantitative SPECT image analysis was compared with 
coronary angiographic findings for assessment of diagnostic 
efficacy (Table 5). The sensitivity, specificity and predictive 
accuracy for detection of coronary artery disease was 83%, 
87% and 84% for adenosine and 82%, 80% and 81% for 
exercise SPECT, respectively. There was slight improve: 
Figure 4. Bull's-eye (top) and short-axis (bottom) images (early and delayed) from 
adenosine SPECT (left) and exercise treadmill SPECT (right) studies. Both studies 
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Table 5. Comparative Efficacy of Quantitative Adenosine and 




Positive predictive value 




82% (73 to 91) 
80% (71 to 89) 
90% (84 to 97) 
67% (55 to 75) 
81% (73 to 93) 
Adenosine 
Thallium* 
83% (74 to 93) 
87% (79 to 95) 
93% (88 to 99) 
70% (59 to 79) 
84% (76 to 94) 
*None of the differences between the two tests are significant. Numbers in 
parentheses represent 95% confidence intervals. 
ment in the sensitivity and specificity for detection of coro-
nary artery disease with quantitative SPECT analysis, as 
compared with the qualitative analysis (previously de-
scribed) for both adenosine and exercise studies. The sensi-
tivity of both adenosine and exercise SPECT studies was 
higher for multivessel disease (94% vs. 94%) than for single-
vessel involvement (71 % vs. 68%). The tomographic quan-
titative data from the two studies were statistically compared 
for stress defect extent and defect severity scores. There 
was 80% agreement between the two tomographic studies 
for the defect size (77% based on a definition of <3% for 
normal defect size) and 79% agreement for the defect sever-
ity scores obtained from the quantitative analysis. 
Statistical analysis revealed myocardial counts in the 
adenosine SPECT stress images to be significantly higher, as 
compared with the counts in the exercise treadmill SPECT 
images (p < 0.0001) with use of the two-tailed t test (on the 
early and delayed image). No significant difference in lung/ 
heart count ratios was found in either set of images (adeno-
sine 0.35 ± 0.6; exercise 0.36 ± 0.5). 
Discussion 
As many as 25% to 30% of the patients with coronary 
artery disease may have limited ability to achieve maximal 
exercise stress (1). Pharmacologic coronary vasodilation has 
been used as an alternative to exercise in myocardial perfu-
sion imaging. Several studies have documented the clinical 
utility of dipyridamole thallium imaging. Dipyridamole has 
been used successfully for accurate diagnosis of coronary 
artery disease (21), identification of patients at high risk for 
cardiac events after major surgery (12) and after myocardial 
infarction (9-11). Dipyridamole mediates coronary vasodi-
lation by inhibiting the cellular reuptake of adenosine, thus 
elevating circulating adenosine level. We have previously 
documented (15) the utility of adenosine as a pharmacologic 
stressor as an adjunct to planar thallium-201 perfusion im-
aging. In addition, thallium kinetics after adenosine admin-
istration are similar to those observed after dipyridamole use 
(17). 
Adenosine thallium-201 tomography. The mechanism of 
adenosine-induced perfusion abnormalities appears to be 
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related to its hyperemic effect. The vasodilation produced 
during stress is moderated in stenotic regions in which 
coronary vascular resistance may already be reduced to a 
minimum in response to the increased pressure gradient. 
Although the coronary flow in normal coronary arteries 
increases 3- to 5-fold (mean 4.4-fold increase) (18) over the 
flow value at rest (compared with a 1.5- to 2-fold increase 
with exercise), the stenotic segments are unable to dilate, 
resulting in detectable differences in perfusion. Because only 
8 (24%) of the 35 patients with a reversible perfusion 
abnormality had ECG evidence of ischemia, it is likely that 
true myocardial ischemia results uncommonly from adeno-
sine infusion. 
Although exercise stress testing is still the method of 
choice because it provides useful information about the 
exercise level attainable by the patient, there may be several 
potential benefits of adenosine over exercise. 1) It causes 
maximal coronary vasodilation in the majority of patients; 2) 
it can be standardized, as opposed to the great variability 
seen with exercise capacity ; and 3) it may be less affected by 
concomitant drug therapy such as beta-adrenergic receptor 
antagonists. 
Mechanism of action of adenosine. Adenosine is a potent 
coronary vasodilator with rapid onset of action and ex-
tremely short half-life ( < 10 s) . It is hypothesized that aden-
osine mediates vasodilation through activation of cellular 
membrane receptors (A1 and A2 adenosine receptors) (22) . 
In previous studies (23) using adenosine to measure coro-
nary flow reserve by Doppler flow catheter, it was found that 
140 p,g/kg per min of intravenous adenosine achieved maxi-
mal coronary hyperemia in virtually all patients and was an 
adequate dose for use in cardiac imaging. The peak flow 
response occurred within 1 to 2 min of the infusion and 
returned to baseline within I to 2 min of discontinuance. The 
vasodilator effect of adenosine is antagonized by aminophyl-
line through competitive inhibition at the receptor level (24). 
Detection of coronary artery disease: clinical utility. In our 
multicenter investigation, adenosine thallium images are 
comparable in quality to exercise thallium images (Fig. 3). 
Our data demonstrate an excellent concordance between 
exercise and adenosine thallium-201 SPECT imaging for the 
detection of coronary artery disease. Adenosine study also 
demonstrates excellent concordance with exercise study for 
detecting individual coronary artery lesions and differenti-
ating between ischemic and fixed abnormalities (Fig. 2). 
Our results indicate comparable sensitivity, specificity 
and accuracy of detection of coronary artery disease with 
use of SPECT imaging with adenosine and exercise stress 
(Table 5). The predictive value of thallium scanning after 
adenosine infusion also compares favorably with that of 
exercise thallium testing (Table 4). There is a slightly im-
proved diagnostic efficacy with quantitative analysis, as 
compared with qualitative analysis, as generally reported by 
other investigators (16). This is particularly important be-
cause the excellent exercise capacity achieved in our sub-
jects is better than that reported by other investigators. The 
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sensitivity and specificity of our results are similar to those 
reported by other investigators (16,25,26) with adenosine 
SPECT thallium-201 imaging. The specificities reported by 
other investigators (16,26) are slightly lower than those 
observed in our series of patients (84% and 75% vs. 87%). 
However, the preliminary experience of other investigators 
with adenosine was in selected patients with known coro-
nary artery disease and included very few subjects with 
normal coronary arteries or healthy volunteers. The sensi-
tivity of adenosine quantitative tomography for multivessel 
disease (94%) is significantly greater than that for single-
vessel disease (71 %), as also reported with dipyridamole 
(2,27). Most of the false negative results (9 of 11 with 
adenosine SPECT and 10 of 12 with exercise treadmill 
SPECT) were seen in patients with single-vessel disease. 
Similar observations were also reported by Nguyen et al. 
(25). 
Similar sensitivity and specificity results have been re-
ported comparing dipyridamole and exercise thallium scin-
tigraphy. Varma et al. (27) reported a concordance of 92% 
between segmental perfusion defects on dipyridamole and 
exercise thallium testing. In a study by Gould et al. (28), 75% 
of patients who had a perfusion defect after exercise also had 
a defect after administration of dipyridamole. Our concor-
dance rates compare favorably with the findings of these 
investigators. 
There were 11 subjects with first-order discordance be-
tween adenosine and exercise SPECT studies based on 
visual analysis. Of these 11, 9 had a defect after adenosine 
administration and two had a defect after exercise. How-
ever, the specificity of the adenosine quantitative SPECT 
study was not significantly different from that of the exercise 
study. The exact significance of more discordance on aden-
osine study with visual analysis is uncertain. 
Thallium kinetics. The significantly greater myocardial 
thallium uptake on stress adenosine images, as compared 
with exercise stress images (p < 0.0001), indicates a more 
potent coronary hyperemic effect of adenosine. Intracoro-
nary Doppler flow studies (18) have documented a greater 
and more consistent increase in coronary blood flow after 
adenosine administration than with dipyridamole. This could 
be the reason why 9 of 10 patients with second-order 
discordance between adenosine and exercise had a revers-
ible defect on adenosine study. The relatively higher initial 
uptake on adenosine study may enhance the disparity in the 
washout rate between normal and stenosed areas. This 
increased disparity would lead to apparent thallium redistri-
bution in the stenosed areas on delayed images. Lung/heart 
ratios were not significantly different on the adenosine and 
exercise SPECT images (early and delayed). Thallium-201 
washout kinetics appear to be similar after adenosine infu-
sion and treadmill exercise because lung/heart ratios on both 
early and delayed images were similar. These findings have 
also been previously documented with planar imaging (17). 
Side effects. Side effects resulting from adenosine infu-
sion were frequent but transient in general. Overall, the 
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adenosine infusion protocol for 6 min was well tolerated in 
the majority of subjects. No serious, life-threatening condi-
tions such as severe hypotension, persistent arrhythmia or 
death resulted from adenosine administration in our multi-
center investigation. The most frequent side effects were 
chest pain and facial flushing. Chest pain was variously 
described as pressure, heaviness, tightness or flank pain. It 
is not clear whether the respiratory stimulant effect of 
adenosine results in chest discomfort in some cases. How-
ever, the exact mechanism of chest pain after adenosine may 
be similar to that of dipyridamole and has not been well 
understood. Although chest pain occurred in 35 patients, 
only 11 of these also had ST segment depression. It may be 
that some of these cases represent adenosine-induced true 
ischemia, perhaps related to the "coronary steal" phenom-
enon as described by Nguyen et al. (25). 
In the 144 subjects examined, the frequency of second-
degree A V block was 0. 7%. No subject required adjustment 
or termination of the adenosine infusion because of arrhyth-
mias. The incidence of A V block in patients who receive 
adenosine is very low and the risk of serious adverse 
outcome due to A V block is minimized by its very short 
half-life ( < 10 s). This side effect appears to be dose depen-
dent and care should be taken to minimize the bolus effect 
that occurs when thallium is injected directly into the aden-
osine infusion line. 
It has been shown that adenosine has a negative chrono-
tropic effect on the sinus node and a negative dromotropic 
effect resulting in delayed conduction through the A V node, 
presumably because of Arreceptor agonism (29). Because of 
its potential to cause bradycardia as well as A V block, 
continuous ECG and frequent blood pressure monitoring is 
recommended. Patients with greater than first-degree A V 
block who are not protected by a permanent pacemaker 
should not receive adenosine. The concomitant administra-
tion of digitalis, beta-adrenergic blocking agents, calcium 
channel blocking agents or dipyridamole (30) may potentiate 
the risk of developing A V block during adenosine infusion. 
However, in view of the very low incidence and transient 
nature of A V block, the use of adenosine infusion with 
thallium-201 imaging is safe. Intravenous adenosine may not 
be safe in patients with asthma or reactive airway disease 
because of potentiation of bronchospasm (31,32). 
Adenosine infusion produces hemodynamic changes sim-
ilar to those reported after the use of other coronary vaso-
dilator agents such as dipyridamole. Hemodynamic effects 
are known to occur in a dose-dependent fashion. The cause 
of tachycardia is not clear but may result from initial 
relaxation of resistance vessels followed by a compensatory 
increase in the heart rate. 
Limitations. Certain limitations of our study deserve 
some discussion. During our multicenter investigation, the 
coronary angiograms of the subjects with normal angio-
graphic findings and the patients with abnormal findings 
were analyzed visually by multiple observers at different 
investigative sites. In addition, the angiographic interpreta-
256 GUPTA ET AL. 
ADENOSINE AND EXERCISE THALLIUM IMAGING 
tion was based on visual analysis only. However, because 
this was a crossover comparative study, the overall concor-
dance between adenosine and exercise studies should not be 
significantly affected. Also, because our study included only 
patients with relatively low risk coronary artery disease, our 
results should be cautiously extrapolated to patients with 
higher risk coronary artery disease such as patients with 
recent myocardial infarction and those with limited exercise 
reserve. All the tomographic images were interpreted by a 
single reader. However, in view of the blinded interpretation 
of the images, the comparative nature of the trial and the 
acceptable intraobserver variability, this factor would not be 
expected to effect the reliability of the data. 
Conclusions. We conclude that thallium myocardial per-
fusion imaging in conjunction with intravenous adenosine 
administration is a highly accurate noninvasive technique for 
diagnosing the severity and extent of coronary artery dis-
ease. In this group of patients with adequate exercise capac-
ity, the results of adenosine SPECT imaging are comparable 
to those of exercise SPECT imaging. The adenosine infusion 
protocol is safe, logistically easy to perform and sufficiently 
well tolerated. It will probably have a broader clinical 
application to patients who are unable to exercise adequately 
or achieve a maximal exercise level. Because of its ability 
to assess the location and extent of coronary artery disease, 
it may also be a potentially important test in the prognostic 
stratification of patients with known coronary artery disease. 
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